entertainment -WSS

entertainment

author：focus 2025-09-03 12:08:57 - browse：9298

The FDA building -- First Opinion coverage from STAT — Adobe

U.S. regulators on Wednesday approved the first treatment for an ultra-rare disease that causes people to grow bone where it otherwise shouldn’t be, extending an option to patients who have been advocating for access to the medicine.

The treatment, an oral medication that will be marketed as Sohonos, faced some questions about the quality of its data, and was rejected earlier this year by European regulators. But in approving the drug for the treatment of fibrodysplasia ossificans progressiva, or FOP, the Food and Drug Administration concluded that Sohonos’ benefits outweigh its risks.

“I just closed my eyes and looked up to the skies, like ‘Thank you, God,’” said Suzanne Hollywood, whose teenage son, Joey, has been receiving the drug in a clinical trial. “It’s far from perfect, but I’m thrilled for my son, for his future, and for the kids getting diagnosed who might not have to experience what others had to.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Private equity deals in Medicare Advantage declines

hotspot

WSS

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Vaccine advisory panel ACIP left half staffed by HHS

'Revelatory' study finds a smoking impact that remains after quitting

Medicare threatens to cut off funding for HCA's Mission hospital

KalVista pill reduced swelling 'attacks' caused by genetic disease

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Wikipedia

entertainment

explore

ChatGPT in medicine: STAT answers readers' burning questions

Doctors' information doesn't help them choose wisely when sick

Trump demands the U.S. pay no more for drugs than other countries … again

What we’ve learned from the Aduhelm mess

DIEP, the 'gold standard' of breast reconstruction, is under threat

PhRMA lawsuit over Medicare drug price negotiation tossed

Hollywood unions extend contract negotiations for actors

How digital tools helped lower hypertension in marginalized patients

Wildfire smoke exposes gaps in outdoor worker protections

The Readout: Gilead, Bernie Sanders, and other pharma news

knowledge

As AI regulations shape up, health tech startups beg for clarity

Opioid cravings were reduced by anti

Industry veterans launch new biotech VC with $310M

Reporting on presidential health from Reagan to Trump and Biden

As AI regulations shape up, health tech startups beg for clarity

Reporting on presidential health from Reagan to Trump and Biden

explore

hotspot

hotspot

hotspot